Is there a domestic version of erdafitinib? Introduction to the launch of domestic generic drugs

Currently, there is no domestic version of Erdafitinib (Erdafitinib) in China. There are only imported original drugs in the domestic market. Erdafitinib is a targeted drug used to treat advanced or metastatic urothelial cancer. It can inhibit the proliferation and growth of tumor cells by targeting FGFR (fibroblast growth factor receptor) mutations. Although the drug is already on the market in China, it has not been widely popularized due to its short time on the market, and it has not yet been included in medical insurance. Therefore, domestic patients face a high cost burden when purchasing it.

The original drug of erdafitinib is sold at a relatively high price in Hong Kong, China, about more than 20,000 yuan. Since they are not covered by medical insurance in China and it is difficult to purchase them directly, some patients may choose to purchase drugs through overseas channels such as Hong Kong pharmacies. Although prices in Hong Kong are higher than in China, they are still cheaper than in other countries, so some patients choose to obtain drugs through these channels.

To cope with the high cost of drugs, patients can also choose foreign generic drugs, which are more affordable than original drugs. Common foreign generic drugs include the Lao version and the Bangladeshi Yaopin International version. The prices of these generic drugs range from a few hundred yuan to more than 2,000 yuan. Although the price is cheap, its pharmaceutical ingredients are basically the same as the original drugs and can effectively play a therapeutic role. Therefore, for some patients with limited financial conditions, generic drugs have become a viable option.

Although the prices of foreign generic drugs are relatively cheap, patients should still be cautious when choosing to purchase them to ensure that the drugs they purchase meet relevant quality standards. Manufacturers of generic drugs need to be certified. When patients purchase through overseas channels, it is best to choose a reputable pharmacy or supplier to ensure the quality and legality of the source of the drug. At the same time, when patients use generic drugs, they should conduct regular efficacy and safety monitoring to ensure the effectiveness of the treatment.

Reference link:https://www.balversa.com/